• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Here's Why Pfizer's COVID Revenue Could Remain Strong Next Year

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jun 01, 2022 at 07:42: PM
via
  • Pfizer's business will get a big boost from COVID-19 revenue this year.
  • Next year is less certain, but the drugmaker still has multiple opportunities.
  • One potentially promising revenue stream could be considered to treat long COVID.

article source
 

<



Similar threads

cafead
Pfizer Just Took Out $31 Billion in Debt. Here&#039;s Why That&#039;s Good News
Replies
0
Views
132
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Here&#039;s the Single Most Important Detail in Pfizer&#039;s Q3 Update
Replies
0
Views
105
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Here&#039;s the Biotech Pfizer Should Consider Acquiring Next
Replies
0
Views
113
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Here&#039;s How This Vaccine Approval From the FDA Benefits Pfizer
Replies
0
Views
218
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Here&#039;s Why Johnson &amp; Johnson&#039;s Vaccine Could Overtake Both Pfizer and Moderna
Replies
0
Views
130
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote